ASCO 2023 | An overview of novel glioblastoma biomarkers

Manmeet Ahluwalia, MD, MBA, FASCO, Baptist Health South Florida, Miami, FL, describes the emergence of novel biomarkers in glioblastoma, such as circulating tumor DNA (ctDNA). Additional biomarkers can potentially be found in transcriptome or epigenome, where RNA and methylation markers respectively can be analyzed in patients with glioblastoma. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.